Skip to main content
Watch Insiders
ELVHealthcare

Elevance Health Inc (ELV) Insider Trading

In the last 90 days, 1 Elevance Health Inc (ELV) insider reported no open-market purchases and 1 sale totaling $4,658,357. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 22, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 22, 2026Mark KayeEVP & CFOSale10,584$440.13$4,658,357
Jul 17, 2026Gail BoudreauxPresident and CEOOpen Market Purchase2,725$367.79$1,002,230
Jul 17, 2026Ramiro G PeruCorporate insiderOpen Market Purchase1,000$366.05$366,050
Jun 12, 2026Ronald W PenczekCAO & ControllerSale369$403.16$148,766
Jun 11, 2026Robert L Dixon JrCorporate insiderSale151$401.77$60,667
May 19, 2026Ronald W PenczekCAO & ControllerSale1,531$403.13$617,192

Common questions

ELV insider trading FAQ

Are ELV insiders buying or selling?
Over the last 90 days, ELV insiders were net sellers, reporting $0.00 of open-market purchases and $4,658,357 of sales.
When was the last ELV insider purchase?
No open-market insider purchase of Elevance Health Inc stock was reported in the last 90 days.
Where does ELV insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Elevance Health Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.